Literature DB >> 20157341

Synthesis of Biotinylated Tumor-Associated Carbohydrate Antigens for Immunological Studies.

Jianglong Zhu1, Qian Wan, Samuel J Danishefsky.   

Abstract

Syntheses of several biotinylated human cancer-associated carbohydrate antigens for immunological studies are described.

Entities:  

Year:  2009        PMID： 20157341      PMCID： PMC2659755          DOI： 10.1016/j.tetlet.2008.11.113

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN： 0040-4039            Impact factor:   2.415


  9 in total

1.  Site-specific immobilization of biotinylated proteins for protein microarray analysis.

Authors:  Rina Y P Lue; Grace Y J Chen; Qing Zhu; Marie-Laure Lesaicherre; Shao Q Yao
Journal:  Methods Mol Biol       Date:  2004

2.  Preparation and evaluation of unimolecular pentavalent and hexavalent antigenic constructs targeting prostate and breast cancer: a synthetic route to anticancer vaccine candidates.

Authors:  Govind Ragupathi; Fusataka Koide; Philip O Livingston; Young Shin Cho; Atsushi Endo; Qian Wan; Maria K Spassova; Stacy J Keding; Jennifer Allen; Ouathek Ouerfelli; Rebecca M Wilson; Samuel J Danishefsky
Journal:  J Am Chem Soc       Date:  2006-03-01       Impact factor: 15.419

3.  Organic synthesis in pursuit of immunology: large-scale synthesis of peracetylated GM2 glycosylamino acid for preparation of a multiantigenic prostate cancer vaccine.

Authors:  Young Shin Cho; Qian Wan; Samuel J Danishefsky
Journal:  Bioorg Med Chem       Date:  2005-09-01       Impact factor: 3.641

Review 4.  Synthetic glycopeptides for the development of cancer vaccines.

Authors:  Angela Liakatos; Horst Kunz
Journal:  Curr Opin Mol Ther       Date:  2007-02

Review 5.  Synthetic carbohydrate-based antitumor vaccines: challenges and opportunities.

Authors:  Ouathek Ouerfelli; J David Warren; Rebecca M Wilson; Samuel J Danishefsky
Journal:  Expert Rev Vaccines       Date:  2005-10       Impact factor: 5.217

6.  Robust immune responses elicited by a fully synthetic three-component vaccine.

Authors:  Sampat Ingale; Margreet A Wolfert; Jidnyasa Gaekwad; Therese Buskas; Geert-Jan Boons
Journal:  Nat Chem Biol       Date:  2007-09-02       Impact factor: 15.040

7.  Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside.

Authors:  P O Livingston; G Y Wong; S Adluri; Y Tao; M Padavan; R Parente; C Hanlon; M J Calves; F Helling; G Ritter
Journal:  J Clin Oncol       Date:  1994-05       Impact factor: 44.544

8.  Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients.

Authors:  P O Livingston; E J Natoli; M J Calves; E Stockert; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

9.  Prospects for total synthesis: a vision for a totally synthetic vaccine targeting epithelial tumors.

Authors:  Stacy J Keding; Samuel J Danishefsky
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-27       Impact factor: 11.205
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.